These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24981930)

  • 1. Relationships between PON1 Q192R polymorphism and clinical outcome of antiplatelet treatment after percutaneous coronary intervention: a meta-analysis.
    Li P; Bu SH; Lu XT; Li LX; Xu AJ; Tang YN; Zhang J
    Mol Biol Rep; 2014 Sep; 41(9):6263-73. PubMed ID: 24981930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PON1 Q192R genetic variant and response to clopidogrel and prasugrel: pharmacokinetics, pharmacodynamics, and a meta-analysis of clinical outcomes.
    Mega JL; Close SL; Wiviott SD; Man M; Duvvuru S; Walker JR; Sundseth SS; Collet JP; Delaney JT; Hulot JS; Murphy SA; Paré G; Price MJ; Sibbing D; Simon T; Trenk D; Antman EM; Sabatine MS
    J Thromb Thrombolysis; 2016 Apr; 41(3):374-83. PubMed ID: 26573179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations of MTHFR 677C>T polymorphism with cardiovascular disease in patients with end-stage renal disease: a meta-analysis.
    Gao XH; Zhang GY; Wang Y; Zhang HY
    PLoS One; 2014; 9(7):e102323. PubMed ID: 25050994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between the PON1 Q192R polymorphism and coronary heart disease in Chinese: A meta-analysis.
    Zhang Z; Ou J; Cai P; Niu B; Li J
    Medicine (Baltimore); 2018 Jun; 97(26):e11151. PubMed ID: 29952962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraoxonase-1 Q192R polymorphism and antiplatelet effects of clopidogrel in patients undergoing elective coronary stent placement.
    Trenk D; Hochholzer W; Fromm MF; Zolk O; Valina CM; Stratz C; Neumann FJ
    Circ Cardiovasc Genet; 2011 Aug; 4(4):429-36. PubMed ID: 21685174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cx37 C1019T polymorphism may contribute to the pathogenesis of coronary heart disease.
    Zhao L; Li Y; Wu D; Ma T; Xia SY; Liu Z
    Genet Test Mol Biomarkers; 2014 Jul; 18(7):497-504. PubMed ID: 24773516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Meta-analysis on safety and efficacy of dual antiplatelet therapy combining with proton pump inhibitors for patients after percutaneous coronary intervention].
    Che QQ; Wu Q; Liang YB; Sun RM; Lyu QW; Ma JL; Hu H; Lin X; Xu GL; Sun SG; Zhang C; Wang QY; Yu J; Bai F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Feb; 47(2):129-140. PubMed ID: 30818941
    [No Abstract]   [Full Text] [Related]  

  • 8. Contribution of PGR genetic polymorphisms to the pathogenesis of endometrial cancer: A meta-analysis.
    Chen Z; Wang SH; Zhou J; Wu T; Li J
    J Cancer Res Ther; 2015; 11(4):810-7. PubMed ID: 26881523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Both PON1 Q192R and CYP2C19*2 influence platelet response to clopidogrel and ischemic events in Chinese patients undergoing percutaneous coronary intervention.
    Chen Y; Huang X; Tang Y; Xie Y; Zhang Y
    Int J Clin Exp Med; 2015; 8(6):9266-74. PubMed ID: 26309584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No association of paraoxonase-1 Q192R genotypes with platelet response to clopidogrel and risk of stent thrombosis after coronary stenting.
    Sibbing D; Koch W; Massberg S; Byrne RA; Mehilli J; Schulz S; Mayer K; Bernlochner I; Schömig A; Kastrati A
    Eur Heart J; 2011 Jul; 32(13):1605-13. PubMed ID: 21527445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of PON1 Gene Promoter DNA Methylation and Genetic Variations on the Clinical Outcomes of Dual Antiplatelet Therapy for Patients Undergoing Percutaneous Coronary Intervention.
    Lei HP; Yu XY; Wu H; Kang YH; Zhong WP; Cai LY; Zhang MZ; Chen JY; Mai LP; Ding QS; Yang M; Zhong SL
    Clin Pharmacokinet; 2018 Jul; 57(7):817-829. PubMed ID: 28875477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of PON1 Q192R genetic polymorphism on clopidogrel efficacy and cardiovascular events in the Clopidogrel in the Unstable Angina to Prevent Recurrent Events trial and the Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events.
    Paré G; Ross S; Mehta SR; Yusuf S; Anand SS; Connolly SJ; Fox KA; Eikelboom JW
    Circ Cardiovasc Genet; 2012 Apr; 5(2):250-6. PubMed ID: 22368149
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Lu Y; Li CY; Lin SS; Yuan P
    Exp Ther Med; 2014 Aug; 8(2):607-613. PubMed ID: 25009628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant association between CYP1A1 T3801C polymorphism and cervical neoplasia risk: a systematic review and meta-analysis.
    Xia L; Gao J; Liu Y; Wu K
    Tumour Biol; 2013 Feb; 34(1):223-30. PubMed ID: 23055196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet reactivity-adjusted antiplatelet therapy in patients with percutaneous coronary intervention: a meta-analysis of randomized controlled trials.
    Xing Z; Tang L; Zhu Z; Huang J; Peng X; Hu X
    Platelets; 2018 Sep; 29(6):589-595. PubMed ID: 28895771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of an association between Paraoxonase 1 gene polymorphisms (Q192R, L55M) and Alzheimer's disease: a meta-analysis.
    Pi Y; Zhang L; Chang K; Li B; Guo L; Fang C; Gao C; Wang J; Xiang J; Li J
    Neurosci Lett; 2012 Aug; 523(2):174-9. PubMed ID: 22776645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between nine candidate genetic polymorphisms with coronary heart disease : A meta-analysis.
    Li Q; Du Q
    Herz; 2020 Dec; 45(Suppl 1):15-28. PubMed ID: 31041492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between IL-1A (-889C/T) polymorphism and susceptibility of chronic periodontitis: A meta-analysis.
    Feng X; Liu J
    Gene; 2020 Mar; 729():144227. PubMed ID: 31759990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraoxonase (PON1) polymorphisms Q192R and L55M are not associated with human longevity: A meta-analysis.
    Wei GZ; Zhu MY; Wang F; Zhao YG; Li SS; Liu TY; Luo Y; Tang WR
    Z Gerontol Geriatr; 2016 Jan; 49(1):24-31. PubMed ID: 25962362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein A5 gene promoter region-1131T/C polymorphism is associated with risk of ischemic stroke and elevated triglyceride levels: a meta-analysis.
    Pi Y; Zhang L; Yang Q; Li B; Guo L; Fang C; Gao C; Wang J; Xiang J; Li J
    Cerebrovasc Dis; 2012; 33(6):558-65. PubMed ID: 22688093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.